Over the last 5 years, physical methods of plasmid delivery have revolutionized the efficiency of nonviral gene transfer, in some cases reaching the efficiencies of viral vectors. In vivo electroporation dramatically increases transfection efficiency for a variety of tissues. Other methods with clinical precedent, pressure-perfusion and ultrasound, also improve plasmid gene transfer. Alternatives such as focused laser, magnetic fields and ballistic (gene gun) approaches can also enhance delivery. As plasmid DNA appears to be a safe gene vector system, it seems likely that plasmid with physically enhanced delivery will be used increasingly in clinical trials.
Progress
Plasmid-based gene transfer has advantages compared to the use of viral vectors Recombinant viral vectors have been developed as highly efficient methods for gene delivery to a variety of tissues. The efficiency of these vectors is due to the presence of viral proteins that interact with cell surface receptors. Unfortunately, these viral proteins evoke specific immune responses that can limit the ability to re-administer the vector. This may be a particular problem in translation of preclinical studies to human treatments, as a significant proportion of the population may have previously encountered the virus and thus have neutralizing antibodies.
In contrast, plasmid vectors are composed entirely of covalently closed circles of double-stranded DNA with no associated proteins. However, gene delivery with plasmid vectors is highly inefficient unless the DNA is either associated with other molecules and/or physical energy is applied to aid cell entry. The use of liposomes and dendrimer complexes has enhanced gene delivery to some tissues in vivo, but the most important improvement has been the use of physical delivery systems that enable plasmid-based gene delivery to reach efficiencies close to that achieved with viral vectors.
Plasmid DNA, although itself a complex molecule, is substantially easier to mass-produce and quality control than are viral vectors. These issues, together with the low immunogenicity and lack of integration seen with plasmid DNA, make it a highly attractive reagent for human gene therapy provided that a high efficiency delivery can be achieved. Clinical trials to date using naked plasmid DNA have reported no ill effects. 1, 2 The physical methods shown to enhance plasmid transfection in vivo are reviewed below. All methods enhance gene transfer by bringing the plasmid DNA into closer proximity to the cell membrane and/or cause temporary microdisruption of the cell membrane, thus increasing the passage of plasmid into the cell.
Application of an electrical field dramatically enhances plasmid gene transfer in vivo
The most substantial change in the efficiency of plasmidbased gene transfer has been seen when delivery of plasmid is followed by the application of a series of electrical pulses as a form of in vivo electroporation (also referred to as electropermeabilization or electrotransfer). This technology is based on the earlier studies of in vitro electroporation and in vivo delivery of macromolecules to local tumours. The latter methodology has been successfully taken through to clinical trials with the cytotoxic drug bleomycin. 3 In vivo electroporation of plasmid DNA was first used for skin and liver but skeletal muscle has recently attracted a lot of attention, as expression of the episomal plasmid can be long lived in this tissue. Indeed, a wide range of tissues have been studied including skin, kidney, lung, liver, skeletal and cardiac muscle, joints, spinal cord, brain, retina, cornea and the vasculature. [4] [5] [6] [7] In most studies, electroporation increased gene expression by 100-to 1000-fold compared to injection of naked plasmid DNA. The exact mechanism by which delivery of plasmid into cells is enhanced is not certain, although it is clear that membranes become effectively permeable once a critical voltage has been achieved (in the order of 200 V/cm in vivo). This is thought to occur by the formation of hydrophilic pores and subsequent movement of plasmid through these pores as a local electrophoretic effect. A recent paper has challenged this widely held view. Golzio et al 8 used fluorescently labelled plasmid to visualize the interaction with single cells in vitro. In their system, plasmid was seen to accumulate at the cell membrane via an electrophoretic effect but did not immediately move into the cytosol. Movement into the cytoplasm was relatively slow and continued after the application of the electrical field ended. This is consistent with the DNA active uptake mechanism proposed by Budker et al, 9 but may represent a novel physical interaction with the cell membrane as, with time, the plasmid that had not yet entered the cytoplasm became inaccessible to a DNA dye. However, this plasmid accumulation has yet to be observed in vivo and the complex organization of tissues such as muscle may significantly modify this process. Very recently, Bureau et al 10 reported the existence of a pool of plasmid that appears to escape the attention of extracellular nucleases and can be successfully electrotransfered up to 4 h after injection of the DNA.
The choice of electrode design is currently very variable and there is a clear need for good comparative studies. Zhang et al 11 examined skin electroporation using a calliper electrode and compared this to a meander electrode (the latter being an array of interlocking positive and negative electrodes; Figure 1a ). Both were equally effective but the meander electrode appears to be a more patient-friendly design as it avoids the need to pinch the skin between the callipers. For other tissues such as liver and muscle, there is a choice between plate and needle electrodes (Figure 1b and c) . In general, the plate electrodes appear to give a more uniform electrical field and are more commonly used for small animals studies but they may not be suitable for electrotransfer in large animals due to the large electrical fields that would need to be applied to larger tissues. Figure 1 Meander (a), calliper (b) and needle (c) electrodes used for in vivo electrotransfer. In the case of the meander electrode, an electrical field is generated between each positive and negative electrode with part of the field entering the tissue. This electrode design is the least invasive of the three. With the calliper electrodes, a near-uniform electrical field is generated between the electrode plates. With needle electrodes, a field is generated between the needles. In some cases, multiple needle electrodes have been used.
Electroporation and other physical methods DJ Wells followed by a series of low-voltage pulses. They proposed that the initial pulse effected an electroporation of the membrane and that the subsequent pulses electrophoresed the DNA into the muscle fibre. Currently, the majority of papers appear to use a pattern averaging 6-10 pulses of 20-40 ms at 1 Hz with a field strength in the order of 200 V/cm. One of the limitations of the electrotransfer is that there can be substantial damage associated with the procedure and that this can limit the efficiency of transfection. 13 A recent paper by Durieux et al 14 convincingly demonstrates that muscle damage is closely associated with the presence of the plasmid DNA during the electrotransfer and is made worse when the LacZ reporter gene is expressed. Modification of the magnitude and duration of the electrical pulses can ameliorate but not entirely prevent all the plasmid-associated damage following treatment of skeletal muscle.
Dean et al 15 have recently provided a dramatic demonstration of the potential of in vivo electroporation for the lung. They applied calliper electrodes either side of the thorax of mice after intratracheal instillation of a solution of plasmid DNA. They showed substantial short-term reporter gene expression in the lung following this procedure with low mortality in the treated animals. Gene expression was seen predominantly in the peripheral alveoli and in both the epithelium and deeper cells. Histological analysis of the lungs 24 h after treatment did not reveal any obvious signs of damage. Thus electroporation appears a relatively safe procedure in the lungs. Application to humans might be possible using bronchoscope-directed electrodes but would only result in treatment of local areas of the lung.
Other recently developed targets for electroporation include joints, 16 spinal cord 17 and the retina. 18 Thus, Matsuda and Cepko 19 have reported that very high gene transfer efficiencies into retinal cells, in particular the photoreceptors, can be achieved with electroporation in neonatal rats and mice. We have demonstrated that electroporation can also be used to deliver oligonucleotides to muscle, specifically for antisense-mediated exon skipping in dystrophic skeletal muscle. 20 Electroporation has been extensively tested for gene transfer into tumours. Even the transfer of empty plasmid vector is sufficient to cause significant tumour regression in some models. 21 Electroporation of plasmids containing interleukin 12 (IL-12) and interleukin 18 (IL-18) has been shown to produce a synergistic effect in inhibiting tumour growth, both for the treated tumour and also for the untreated contralateral tumour. 22 In another study, electrotransfer of a combination of bleomycin and a plasmid encoding IL-12 not only produced complete remission in a proportion of mice carrying a subcutaneous melanoma but also provided a significant protective effect against established metastases. 23 Given the success of electrotransfer of bleomycin in many clinical trials, 3 the combination with gene transfer appears to offer further potential in the delivery of a clinically effective treatment.
Liu and Huang 24 have used a combination of vascular delivery with electroporation for the liver. Intravenous administration of plasmid via the tail vein in the mouse enhanced gene expression in the liver following electroporation compared to direct injection into the liver before electroporation. Expression was further improved by temporarily blocking blood flow through the vena cava or the portal vein and hepatic vein. It remains to be seen if this combination approach will work in other tissues.
Electrotransfer can also be used for genetic vaccination, and a number of laboratories have demonstrated substantial improvements in responses to a variety of antigens. [25] [26] [27] Tjelle et al 28 have proposed that electrotransfer of plasmid DNA encoding immunoglobulins might be an alternative to the administration of monoclonal antibodies in the treatment of a variety of conditions and have demonstrated prolonged expression in both mice and sheep.
An interesting development of in vivo electroporation for research purposes has been the application of this technology to the developing central nervous system (CNS) of rodent embryos. [29] [30] [31] Using very fine electrodes, it is possible to deliver plasmids to defined regions of the developing brain to track cell migration and to modify patterns of development. Recently, Wei et al 32 have extended this technology to adult rodents, showing that it is possible to express selectively plasmid-based constructs in specific regions of the adult CNS.
Finally, integration of plasmid DNA has not been previously reported following direct intramuscular injection despite a number of careful studies from several laboratories. In contrast, Wang et al 33 have recently reported that integration of plasmid DNA can be detected following electroporation of skeletal muscle in vivo. However, this is still a very rare event, below the level of background genomic mutation, and so is unlikely to be a significant safety risk with respect to clinical application.
Pressurized vascular delivery improves plasmid transfection in vivo with a more widespread distribution than local injection As plasmid DNA contains no proteins for attachment to cellular receptors, naked plasmid has no specific targeting to different cell types and thus it is essential that the DNA is placed in close contact with the desired cell type. The use of pressure to achieve this close contact has also dramatically increased the efficiency of delivery, in particular to liver and skeletal muscle.
The use of rapidly delivered extremely high volume (equivalent to total blood volume) injections via the tail vein of the mouse leads to highly efficient transfection of hepatocytes throughout the majority of the liver. A series of very recent papers have attempted to explain the physical basis for this phenomenon. Zhang et al 34 have demonstrated that hydrodynamic gene delivery leads to a transient decrease in heart function and a rapid rise in venous pressure that leads to enlargement of the fenestrae in the liver sinusoids. This in turn allows hydrostatic pressure to act on the hepatocyte cell membranes causing transient pores or defects, a process they term hydroporation. Other groups [35] [36] [37] have demonstrated that the dynamics of the transfection process support this concept of transient hyperpermeability of the hepatocyte cell membrane and do not support the active uptake mechanism proposed by Budker et al. 9 The use of this hydrodynamic technique in the mouse has allowed comparison of the effect of different vector sequences, 38 the testing of optimal expression constructs 39 and the efficient delivery of siRNA to the Electroporation and other physical methods DJ Wells liver. 40, 41 The same technique has been applied to rats. 42 However, this approach, while useful for studies in rodents, is not directly applicable to humans. Eastman et al 43 examined local hydrodynamic delivery into specific lobes of the rabbit liver using balloon cuff catheters. They demonstrated that pressure-mediated local delivery can be safely achieved with this approach without the need for surgery to expose the liver. As with the tail-vein injections, there were only transient elevations in liverspecific enzymes released into the blood. Pressuremediated plasmid delivery has also been used for other tissues, such as the kidney. 44 The importance of local hydrostatic pressure has been shown by the work of Liu et al, 45 who report that mechanical massage of the liver increases gene transfer following intravenous delivery of plasmid DNA.
Huang et al 46 have also successfully delivered plasmid to the diaphragm using the venous approach with temporary occlusion of the cranial vena cava. For delivery to limb musculature, pressure-mediated plasmid delivery is generally performed via the arterial system. This approach has been used for delivery of plasmid to multiple muscles in the temporarily isolated limbs of primates, 47 and isolated limb perfusion is an established technique in clinical practice for the treatment of tumours. 48 Plasmid uptake and expression was more efficient than for direct intramuscular injection and was detected in all muscles of the perfused limb. There have been no subsequent publications using this gene delivery methodology, although unpublished studies were reported in the review by Herweijer and Wolff. 49 We have observed expression of human minidystrophin (using a species-specific antibody) in up to 30% of muscle fibres in the limb muscles of rats following pressure-mediated arterial delivery (Fletcher, Wells and Wells, unpublished results). The same technique is currently being used to deliver dystrophin to dystrophic muscle in the legs of the canine model of X-linked muscular dystrophy. 50 A very recent paper from Huang's group 51 has shown that it may not be necessary to use the arterial route to deliver plasmid to skeletal muscle. They demonstrated remarkably high efficiency delivery of a dystrophin plasmid to dystrophic mouse muscle by both arterial and venous routes provided that there was a temporary occlusion of the blood supply that increased pressure within the muscle vascular bed.
Clinically applicable ultrasound can enhance plasmid-based gene delivery in vivo
In vivo electroporation-and pressure-mediated delivery, although very efficient, are rather invasive techniques. Consequently, other methods have been examined for their ability to provide motive force in the delivery of plasmid DNA. Ultrasound is in general clinical use for both therapeutic and diagnostic purposes. Low-level ultrasound is used for diagnostic imaging, ultrasonic shock waves are used in the treatment of kidney stones (lithotripter) and high-intensity focused ultrasound (HIFU) is used for the thermal destruction of tumours. A number of groups have demonstrated the utility of these various modalities of ultrasound in enhancing the delivery of plasmid DNA. For example, Taniyama et al have used low-dose (1 min at 1 MHz, 2.5 W/cm 2 ) ultrasound to improve gene delivery in skeletal muscle 52 and the carotid artery. 53 Likewise, other groups have used a similar approach for gene transfer into skeletal muscle [54] [55] [56] and the heart. 57, 58 In contrast, Huber et al 59 used HIFU (1 min at 0.85 MHz, 155 W over a 2 mm width) to perform gene transfer to the carotid artery on the grounds that this modality allows specific localization of the enhanced gene transfer. They demonstrated an eight-fold increase in total reporter gene expression with HIFU alone and a 17.5-fold increase when ultrasound contrast bubbles were used. However, the reported increase in transfection with contrast enhanced HIFU is not significantly different from the fold increases shown in many of the lower power delivery ultrasound studies. HIFU and lithotripter shock waves have been used to simultaneously ablate tumours and perform gene transfer into the residual mass but gene expression was very variable, possibly due to variable degrees of tumour ablation. 60 The application of ultrasound results in acoustic cavitation that can disrupt tissues and produce transient membrane permeabilization, thus enhancing the delivery of plasmid to the cytoplasm. Nucleation agents such as ultrasound contrast agents can enhance cavitation, and several studies have examined a range of such contrast agents, concluding that albumin-coated octa-fluoropropane gas microbubbles (Optison) is preferable to several other commonly available agents. A combination of electroporation and ultrasound (electro-sonoporation) has been described by Yamashita et al. 63 In their study, electro-sonoporation was superior to either electroporation or ultrasound alone. However, it is difficult to compare this study to others in the field due to insufficient methodological details for the electroporation component.
Other physical methods such as laser, magnetic fields and ballistic delivery can also be used to increase in vivo gene transfer but are generally less effective Focused laser provides an alternative energy source, and the potential of this technique was demonstrated in a recent paper by Zeira et al. 64 The authors reported that gene delivery into muscle could be enhanced by application of a femtosecond infrared laser (5 s at 30 mW) and they compared this to in vivo electroporation of the same quantity of DNA into the same muscle (16 Â 20 ms pulses at 200 V/cm). The authors concluded that there was a similar efficiency of gene delivery and that this was accompanied by substantially less damage when using laser beam gene transduction (LBGT). The mechanism by which the laser enhanced gene transfer was not clear but likely involved local disruption of the muscle cell membrane. Two issues arise from this work. The comparison with electroporation was not unexpected as several other groups, including ourselves, have shown that multiple pulses at 200 V/cm cause substantial muscle damage and that modifications to the Electroporation and other physical methods DJ Wells protocol can reduce this damage. 13, 65 Secondly, the laser was focused to 2 mm under the skin whereas substantially deeper focusing would be required for percutaneous delivery to human skeletal muscle. It remains to be seen if LBGT can be significantly scaled up in studies of larger muscles or other tissues.
Strong magnetic fields can also be used to provide an energy source to assist gene transfer when plasmid DNA is coupled to paramagnetic nanoparticles. Application of magnetic fields following local injection of plasmidassociated nanoparticles (magnetofection) has been reported to enhance in vivo gene transfer to the gastrointestinal tract and the vasculature of the ear. 66 The improved gene transfer associated with magnetofection does not appear to be as substantial as that seen with hydrodynamic delivery or electroporation, although direct comparisons have not yet been made.
Bombardment of tissues by plasmid-coated microparticles has previously received considerable attention for gene transfer in animals after originally being developed for gene delivery to plants. The application of the gene gun technology in animals has been limited to superficial tissues such as the skin. Recent papers have continued to use this approach for applications such as gene therapy of bladder pain using pro-opiomelanocortin gene transfer in a rat model, 67 the transfer of IL-10, IL-12 and B7.1 into murine tumors, 68 gene transfer into the heart, 69 gene transfer into mouse embryos 70 and treatment via the skin of a mouse model of lysosomal acid maltase deficiency (GAA, also known as glycogen storage disease type II). 71 Most significantly, Dileo et al 72 have recently reported a new design of gene gun that delivers microparticles at a higher pressure, thus accessing subcutaneous tissues, such as muscle or tumours, and consequently achieving longer-term gene expression.
Ballistic gene delivery has been used most extensively for the delivery of DNA vaccines to the skin. This approach has been reported to be superior to other methods of plasmid delivery to the skin 73, 74 but tends to generate a Th2 (humoral) rather than the Th1 (cytotoxic) immune response that commonly follows intramuscular administration. 75, 76 This difference in the nature of the immune response can be modified by different boost strategies following the initial priming vaccination by gene gun delivery of plasmid DNA. 77 
Prospects Application of physical methods for human gene therapy
The dramatic improvements in plasmid gene transfer and expression achieved by the variety of physical methods reviewed above have transformed the use of plasmid vectors as a laboratory tool for answering both basic and applied research questions. Although there are clinical precedents for the use of electroporation, isolated limb/organ perfusion and ultrasound, it still remains to be seen if any of these approaches will be translated into gene therapy clinical trials. The most likely areas of application will be for local administration to tumours and for enhanced genetic vaccination. Previous genetic vaccination studies using naked plasmid DNA have been disappointing. 78 However, electrotransfer into mouse muscle can produce a more dramatic induction of CD8 T cells than any other form of vaccination including the use of live vaccinia virus. 79 Importantly, the use of electroporation maintains a high efficiency of vaccination when pre-clinical studies are moved from small to large animal models. 80 The recent Phase 1 clinical trial studying the safety of plasmid-based gene transfer of dystrophin in Duchenne and Becker muscular dystrophy patients in France has been completed and initial reports confirm that no safety problems were encountered, although as expected the efficiency of gene delivery using direct intramuscular injection was very low compared to similar studies in dystrophic mice. Studies of arterial pressure-mediated gene transfer in dystrophic dogs show promising results and it is hoped that the same technique but involving an individual muscle will be the subject of the next clinical trial. 50 A similar method has also been used to deliver adeno-associated viral vectors to multiple muscles in the haemophiliac dog 81 and the use of physical delivery methods may also prove useful for viral as well as nonviral vectors.
Physical enhancement of viral gene delivery has been less widely investigated compared to the delivery of nonviral vectors. Emani et al 82 have reported that optimal coronary artery delivery of adenoviral vectors requires pressures greater than normal systolic but that the threshold for this effect is limited and trebling the pressure induces marked cardiac damage. Similarly, high pressure was used to deliver an adenoviral vector via a double balloon catheter in the rat coronary artery. 83 Ultrasound has also been used to deliver adenoviral vectors to the heart and was dependent on the presence of liposome microbubbles. 84 Indeed, ultrasound may be used more in the future for viral vectors where it is desirable to target specific tissues.
